Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |